• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Jushi Holdings Puts Growth Plans in High Gear

The cannabis cultivator and retailer plans to nearly double its number of dispensaries in 2021.
By DEBRA BORCHARDT
Jan 13, 2021 | 10:00 AM EST
Stocks quotes in this article: JUSHF

Canaccord Genuity has initiated coverage on Jushi Holdings Inc. (JUSHF) with a speculative Buy rating and a $7.50 price target. The stock closed Tuesday at $5.74.

Analyst Bobby Burleson cited Jushi's planned store growth for 2021 and its exposure to the Illinois and Pennsylvania markets for the rating. The analyst also noted the potential for the Virginia market, although it is early to know whether this market will be as promising as others.

While other brick-and-mortar stores are closing right and left, cannabis dispensaries are proving that physical retail isn't dead. Jushi is expected to operate 23 stores by the end of the year. It currently has 13 stores, mostly located in Pennsylvania and Illinois, with a slight presence in California and a small location in Virginia. Virginia is too early to call but could be like Arizona and Pennsylvania based on approved conditions. It is also a limited license state, which bodes well for companies that receive approval early. Burleson wrote that Jushi "is the only operator licensed for the densely populated, affluent metro area of Northern Virginia just outside of Washington, D.C."

Expansion is planned for California, Nevada and Ohio. The company has a modest market share in the Golden State but looks to increase that footprint. Jushi's current business in Nevada is as a cultivator and producer, but Burleson said there could be a retail opportunity there in the future. Ohio is a cultivation business at this time and will be operational in 2021.

Jushi has eight dispensaries in Pennsylvania, which is a medical-use-only state. The company has plans for another seven and Burleson estimates Pennsylvania will account for 45% of Jushi's 2021 revenue. The state has more than 100 active dispensaries with 500,000 registered patients and caregivers. Retail sales have hit roughly $1.1 billion since the program was established. Traffic and retail sales have jumped as a result of the Covid-19 pandemic due to anxiety and disruptions in the illegal markets.

While all this sounds great, Pennsylvania could see sales decline if New Jersey legalizes recreational use Those consumers who are really recreational users but are using medical cards may be motivated to cross the state line to make purchases. However, support for full legalization in Pennsylvania is growing, and state budget shortfalls due to the pandemic could serve as the tipping point for such legalization. Burleson said full legalization could happen in Pennsylvania by 2023 and it is estimated the state could bring in $580 million in annual tax revenues.

Jushi has six stores in the Philadelphia metro area and a modest but growing presence in Pittsburgh. The company also has a store in downtown Scranton and a future location in Hazleton, where the next closest dispensary will be 40 minutes away.

Illinois is Jushi's second-largest market and makes up roughly 32% of Burleson's 2021 revenue forecast for the company. The state has been crushing it when it comes to sales. There are 110 licensed dispensaries in the state and Illinois clocked $87 million in sales in December. Burleson wrote that a study by Freedman and Kolski suggested the state could generate up to $2.6 billion in annual sales. The company has two operational dispensaries that are already bringing in $50 million a year. Jushi plans on opening two more stores early this year.

Jushi's best-performing store is in Sauget, which is known as a Midwestern entertainment location. It is connected by a bridge to St. Louis and is considered to be Las Vegas-like for its party atmosphere. Jushi just opened a second Sauget store at the end of December and plans another Bloomington store in January. The company also has a craft grow license, which the analyst believes would allow the company to go vertical if it chooses.

Virginia is a new medical-only state with high barriers to entry. The state set up five Health Service Areas (HSA) and each permit holder must be vertically integrated. The holders can then open an additional five stores. Jushi said it believes the Virginia store could bring in $20 million by midyear. The real bet is on the future. The location Jushi snagged is the most densely populated HAS and is located outside of Washington, D.C. The population is known to have high incomes and is home to many millennials, which is a strong demographic for customers.

"We expect a healthy multiple for Jushi to persist in coming quarters, with the stock catalyzed in large part by new store openings (we anticipate 10 new stores in 2021)," Burleson wrote. The company is sitting on a cushion of $121 million in cash and its growth is fully funded. In addition to more stores, Jushi could make acquisitions. This company has grown quickly but in a methodical way.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Borchardt had no positions in the stocks mentioned.

TAGS: Investing | Small Cap | Stocks | Marijuana | Real Money | Cannabis

More from Stocks

Jim Cramer: Housing Is Our Bridge

Jim Cramer
Jan 21, 2021 3:59 PM EST

Do not fear the housing sales boom -- this is good news and I'll tell you why.

Cord-Cutting FuboTV and Advertising Platform PubMatic Are Not Buys Here

Bruce Kamich
Jan 21, 2021 2:59 PM EST

Our look at the stocks of both FUBO and PUBM.

Hyliion Should Keep Truckin'

Timothy Collins
Jan 21, 2021 2:49 PM EST

I see a good trade down the road in this commercial fleet alternative-power truck name.

Jim Cramer: You Just Won Powerball, Now What?

Jim Cramer
Jan 21, 2021 2:24 PM EST

Remember, you only need to get rich once.

Aim High With This Defensive Dividend Stock

Bob Ciura
Jan 21, 2021 1:40 PM EST

Lockheed Martin is a classic defense stock that also gives investors an offensive position.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:16 AM EST CHRIS VERSACE

    Worst Stocks to Buy for the Biden Presidency

    Biden's take on the minimum wage, likely moves on ...
  • 08:35 AM EST GARY BERMAN

    Thursday Morning Fibocall for 1/21/2021

    SPX (Long-Term View) The 1/20/21 NEW high @ 3859...
  • 11:38 AM EST CHRIS VERSACE

    Best Stocks to Buy for the Biden Presidency

    President-elect Biden's massive stimulus plan, int...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login